Accéder au contenu
Merck

Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition.

JCI insight (2016-08-03)
Marcin P Iwanicki, Hsing-Yu Chen, Claudia Iavarone, Ioannis K Zervantonakis, Taru Muranen, Marián Novak, Tan A Ince, Ronny Drapkin, Joan S Brugge
RÉSUMÉ

High-grade serous ovarian carcinoma (HGS-OvCa) harbors p53 mutations and can originate from the epithelial cell compartment of the fallopian tube fimbriae. From this site, neoplastic cells detach, survive in the peritoneal cavity, and form cellular clusters that intercalate into the mesothelium to form ovarian and peritoneal masses. To examine the contribution of mutant p53 to phenotypic alterations associated with HGS-OvCA, we developed live-cell microscopy assays that recapitulate these early events in cultured fallopian tube nonciliated epithelial (FNE) cells. Expression of stabilizing mutant variants of p53, but not depletion of endogenous wild-type p53, in FNE cells promoted survival and cell-cell aggregation under conditions of cell detachment, leading to the formation of cell clusters with mesothelium-intercalation capacity. Mutant p53R175H-induced phenotypes were dependent on fibronectin production, α5β1 fibronectin receptor engagement, and TWIST1 expression. These results indicate that FNE cells expressing stabilizing p53 mutants acquire anchorage independence and subsequent mesothelial intercalation capacity through a mechanism involving mesenchymal transition and matrix production. These findings provide important new insights into activities of mutant p53 in the cells of origin of HGS-OvCa.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Anticorps monoclonal anti-βactine, souris, clone AC-15, purified from hybridoma cell culture
Sigma-Aldrich
Anti-fibronectine antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-N-Cadherin antibody, Mouse monoclonal, clone GC-4, purified from hybridoma cell culture